Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Short term Debt: 2010-2014

Historic Short term Debt for Madrigal Pharmaceuticals (MDGL) over the last 5 years, with Dec 2014 value amounting to $9.2 million.

  • Madrigal Pharmaceuticals' Short term Debt fell 24.92% to $6.9 million in Q3 2015 from the same period last year, while for Sep 2015 it was $6.9 million, marking a year-over-year decrease of 24.92%. This contributed to the annual value of $9.2 million for FY2014, which is 2.51% down from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Short term Debt of $9.2 million as of FY2014, which was down 2.51% from $9.5 million recorded in FY2013.
  • Madrigal Pharmaceuticals' Short term Debt's 5-year high stood at $9.5 million during FY2013, with a 5-year trough of $3.3 million in FY2010.
  • Moreover, its 3-year median value for Short term Debt was $8.6 million (2012), whereas its average is $8.2 million.
  • In the last 5 years, Madrigal Pharmaceuticals' Short term Debt skyrocketed by 87.15% in 2012 and then dropped by 2.51% in 2014.
  • Madrigal Pharmaceuticals' Short term Debt (Yearly) stood at $3.3 million in 2010, then climbed by 27.03% to $4.2 million in 2011, then reached $6.1 million in 2012, then spiked by 87.15% to $7.9 million in 2012, then grew by 19.27% to $9.5 million in 2013, then fell by 2.51% to $9.2 million in 2014.